{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:05:29Z","timestamp":1780326329009,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.radonc.2023.109665","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:55:46Z","timestamp":1680702946000},"page":"109665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-5941","authenticated-orcid":false,"given":"Fatima","family":"Tensaouti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0560-6266","authenticated-orcid":false,"given":"Franck","family":"Desmoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gilhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Roques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soleakhena","family":"Ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Albert","family":"Lotterie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Truc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Sunyach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Charissoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-9386","authenticated-orcid":false,"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"P\u00e9ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cohen-Jonathan Moyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109665_b0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.radonc.2023.109665_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061932","article-title":"Tumor Cell Invasion in Glioblastoma","volume":"21","author":"Vollmann-Zwerenz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2023.109665_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-019-5317-x","article-title":"Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging","volume":"19","author":"Laprie","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109665_b0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00234-017-1899-7","article-title":"Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma","volume":"59","author":"Tensaouti","year":"2017","journal-title":"Neuroradiology"},{"key":"10.1016\/j.radonc.2023.109665_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-017-0791-2","article-title":"Subventricular zones: New key targets for glioblastoma treatment","volume":"12","author":"Khalifa","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109665_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-016-2232-8","article-title":"Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?","volume":"130","author":"Khalifa","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109665_b0035","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-016-4234-5","article-title":"Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation","volume":"26","author":"Khalifa","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2023.109665_b0040","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/cancers14112803","article-title":"Glioblastoma Stem-like Cell Detection Using Perfusion and Diffusion MRI","volume":"14","author":"Duval","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2023.109665_b0045","doi-asserted-by":"crossref","first-page":"109486","DOI":"10.1016\/j.radonc.2023.109486","article-title":"Pseudoprogression versus true progression in patients with glioblastoma: A multiapproach analysis","author":"Sidibe","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109665_b0050","doi-asserted-by":"crossref","first-page":"20190026","DOI":"10.1259\/bjro.20190026","article-title":"Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning","volume":"2","author":"Laino","year":"2020","journal-title":"BJR|Open"},{"key":"10.1016\/j.radonc.2023.109665_b0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3171\/jns.1987.66.6.0865","article-title":"Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms","volume":"66","author":"Kelly","year":"1987","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2023.109665_b0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(01)01548-6","article-title":"MR-spectroscopy guided target delineation for high-grade gliomas","volume":"50","author":"Pirzkall","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109665_b0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/neuonc\/now036","article-title":"Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients","volume":"18","author":"Cordova","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2023.109665_b0070","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2007.10.039","article-title":"Proton Magnetic Resonance Spectroscopic Imaging in Newly Diagnosed Glioblastoma: Predictive Value for the Site of Postradiotherapy Relapse in a Prospective Longitudinal Study","volume":"70","author":"Laprie","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109665_b0075","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1016\/j.ijrobp.2012.07.707","article-title":"Evaluation of Lactate as a Predictive Marker of Survival and Local Response to Radiation Therapy in Patients With GBM","volume":"84","author":"Deviers","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109665_b0080","doi-asserted-by":"crossref","unstructured":"JS C, S K, S G, J Z, M T, O K, et al. Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma. Tomography 2016;2:366\u201373. https:\/\/doi.org\/10.18383\/j.tom.2016.00187.","DOI":"10.18383\/j.tom.2016.00187"},{"key":"10.1016\/j.radonc.2023.109665_b0085","first-page":"1","article-title":"A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma","volume":"4","author":"Ramesh","year":"2022","journal-title":"Neuro-OncologyAdv"},{"key":"10.1016\/j.radonc.2023.109665_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11060-008-9685-3","article-title":"Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy","volume":"91","author":"Saraswathy","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109665_b0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1227\/01.NEU.0000079331.21178.8E","article-title":"Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas","volume":"53","author":"Kuznetsov","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2023.109665_b0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/neuonc\/nos334","article-title":"Survival analysis in patients with newly diagnosed glioblastoma using pre-and postradiotherapy MR spectroscopic imaging","volume":"15","author":"Li","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2023.109665_b0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmri.20039","article-title":"Survival analysis in patients with glioblastoma multiforme: Predictive value of choline-to-n-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume","volume":"19","author":"Oh","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2023.109665_b0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11060-008-9719-x","article-title":"Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM","volume":"91","author":"Crawford","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109665_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-1","article-title":"Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost","volume":"8","author":"Ken","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109665_b0120","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mrm.22163","article-title":"Pattern recognition of MRSI data shows regions of glioma growth that agree with DTI markers of brain tumor infiltration","volume":"62","author":"Wright","year":"2009","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.radonc.2023.109665_b0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/nbm.2850","article-title":"Hierarchical non-negative matrix factorization (hNMF): a tissue pattern differentiation method for glioblastoma multiforme diagnosis using MRSI","volume":"26","author":"Li","year":"2013","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109665_b0130","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/nbm.3413","article-title":"Hierarchical non-negative matrix factorization to characterize brain tumor heterogeneity using multi-parametric MRI","volume":"28","author":"Sauwen","year":"2015","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109665_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12880-017-0198-4","article-title":"Semi-automated brain tumor segmentation on multi-parametric MRI using regularized non-negative matrix factorization","volume":"17","author":"Sauwen","year":"2017","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.radonc.2023.109665_b0140","doi-asserted-by":"crossref","first-page":"e4109","DOI":"10.1002\/nbm.4109","article-title":"Analysis of metabolic abnormalities in high-grade glioma using MRSI and convex NMF","volume":"32","author":"Pedrosa de Barros","year":"2019","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109665_b0145","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3390\/cancers13102417","article-title":"Mapping of Metabolic Heterogeneity of Glioma Using MR-Spectroscopy","volume":"13","author":"Franco","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.109665_b0150","article-title":"Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?","author":"Tensaouti","year":"2021","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.radonc.2023.109665_b0155","doi-asserted-by":"crossref","unstructured":"Sculley D. kmeans-test-objective-k-50.eps 2010:1177\u20138.","DOI":"10.1145\/1772690.1772862"},{"key":"10.1016\/j.radonc.2023.109665_b0160","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3174\/ajnr.A1392","article-title":"Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses","volume":"30","author":"Maj\u00f3s","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.radonc.2023.109665_b0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.18383\/j.tom.2018.00051","article-title":"Multivoxel 1 H-MR Spectroscopy Biometrics for Preoprerative Differentiation Between Brain Tumors","volume":"4","author":"Durmo","year":"2018","journal-title":"Tomogr (Ann Arbor, Mich)"},{"key":"10.1016\/j.radonc.2023.109665_b0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejrad.2008.02.033","article-title":"(1)H MR spectroscopy of inflammation, infection and ischemia of the brain","volume":"67","author":"Mader","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.radonc.2023.109665_b0175","first-page":"177","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"CellMetab"},{"key":"10.1016\/j.radonc.2023.109665_b0180","doi-asserted-by":"crossref","unstructured":"Warburg O. On the origin of cancer cells. Science (80-) 1956;123:309\u201314. https:\/\/doi.org\/10.1126\/SCIENCE.123.3191.309\/ASSET\/A8D38B53-799F-4009-AAD3-E77CEF33D301\/ASSETS\/SCIENCE.123.3191.309.FP.PNG.","DOI":"10.1126\/science.123.3191.309"},{"key":"10.1016\/j.radonc.2023.109665_b0185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2023.109665_b0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nic.2012.10.002","article-title":"Brain Proton Magnetic Resonance Spectroscopy: Introduction and Overview","volume":"23","author":"Bertholdo","year":"2013","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.radonc.2023.109665_b0195","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1158\/1078-0432.CCR-16-0702","article-title":"Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response","volume":"22","author":"Kickingereder","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2023.109665_b0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clineuro.2012.11.002","article-title":"Potential of MR spectroscopy for assessment of glioma grading","volume":"115","author":"Bulik","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.radonc.2023.109665_b0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1602\/neurorx.2.2.197","article-title":"Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making","volume":"2","author":"Lin","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.radonc.2023.109665_b0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejrad.2008.03.002","article-title":"Introduction to clinical in vivo MR spectroscopy","volume":"67","author":"Hajek","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.radonc.2023.109665_b0215","first-page":"769","article-title":"Magnetic Resonance (MR) Metabolic Imaging in Glioma","volume":"25","author":"Chaumeil","year":"2015","journal-title":"BrainPathol"},{"key":"10.1016\/j.radonc.2023.109665_b0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2003.08.023","article-title":"3D MRSI for resected high-grade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI","volume":"59","author":"Pirzkall","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109665_b0225","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3171\/jns.2002.97.4.0794","article-title":"Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence","volume":"97","author":"McKnight","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2023.109665_b0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.nicl.2016.09.021","article-title":"Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI","volume":"12","author":"Sauwen","year":"2016","journal-title":"Neuroimage Clin"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:30:02Z","timestamp":1759123802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":46,"alternative-id":["S0167814023002037"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109665","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109665"}}